231 related articles for article (PubMed ID: 22126430)
21. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?
Bonomo RA
Clin Infect Dis; 2011 Feb; 52(4):485-7. PubMed ID: 21258101
[No Abstract] [Full Text] [Related]
22. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman.
Poirel L; Al Maskari Z; Al Rashdi F; Bernabeu S; Nordmann P
J Antimicrob Chemother; 2011 Feb; 66(2):304-6. PubMed ID: 21098539
[TBL] [Abstract][Full Text] [Related]
23. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Panagiotakopoulou A; Daikos GL; Miriagou V; Loli A; Tzelepi E; Tzouvelekis LS
Int J Antimicrob Agents; 2007 Mar; 29(3):360-2. PubMed ID: 17223016
[No Abstract] [Full Text] [Related]
25. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.
Daikos GL; Markogiannakis A; Souli M; Tzouvelekis LS
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1393-404. PubMed ID: 23253318
[TBL] [Abstract][Full Text] [Related]
27. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.
Lin YT; Liu CJ; Fung CP; Tzeng CH
Scand J Infect Dis; 2011 Aug; 43(8):603-8. PubMed ID: 21539500
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
Maherault AC; Nordmann P; Therby A; Pangon B
Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
[No Abstract] [Full Text] [Related]
29. Intrathecal administration of colistin for meningitis due to New Delhi metallo-β-lactamase 1(NDM-1)-producing Klebsiella pneumoniae.
Inamasu J; Ishikawa K; Oheda M; Nakae S; Hirose Y; Yoshida S
J Infect Chemother; 2016 Mar; 22(3):184-6. PubMed ID: 26683242
[TBL] [Abstract][Full Text] [Related]
30. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Roy S; Viswanathan R; Singh AK; Das P; Basu S
J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
[No Abstract] [Full Text] [Related]
31. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.
Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643
[TBL] [Abstract][Full Text] [Related]
32. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
33. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
34. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
[No Abstract] [Full Text] [Related]
35. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
Hirsch EB; Tam VH
J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670
[TBL] [Abstract][Full Text] [Related]
36. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
[No Abstract] [Full Text] [Related]
37. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
38. Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Camargo JF; Simkins J; Beduschi T; Tekin A; Aragon L; Pérez-Cardona A; Prado CE; Morris MI; Abbo LM; Cantón R
Antimicrob Agents Chemother; 2015 Oct; 59(10):5903-8. PubMed ID: 26386029
[TBL] [Abstract][Full Text] [Related]
39. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Lee CH; Su LH; Tang YF; Liu JW
J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
[TBL] [Abstract][Full Text] [Related]
40. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
